We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current 5CV market cap is 709.6M. The company's latest EPS is EUR -1.1615 and P/E is -2.76.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 23M | 73.02M | 744.92M | 105.35M | 61.71M |
| Operating Income | -99.5M | -109.82M | -412.26M | -231.1M | -275.4M |
| Net Income | -99.87M | -129.12M | -411.72M | -249.03M | -260.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 130.62M | 1.51B | 1.16B | 860.47M | 788.25M |
| Total Liabilities | 173.42M | 800.01M | 469.77M | 327.22M | 271.31M |
| Total Equity | -42.8M | 711.35M | 688.48M | 533.25M | 516.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -86.96M | 522.4M | -733.13M | -286.18M | -267.89M |
| Investing | 28.18M | -45.27M | -127.9M | -93.5M | -55.2M |
| Financing | 67.98M | 819.83M | 344.96M | 63.17M | 230.89M |
| Market Cap | 709.6M |
| Price to Earnings Ratio | -2.76 |
| Price to Sales Ratio | 11.65 |
| Price to Cash Ratio | 1.79 |
| Price to Book Ratio | 1.39 |
| Dividend Yield | - |
| Shares Outstanding | 223.99M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (0.63%) |
| Company Name | CureVac BV |
| Address |
friedrich-miescher-strasse 15 tubingen 72076 |
| Website | https://www.curevac.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
